Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86399 | Target Info | |||
Target Name | Bromodomain-containing protein 2 (BRD2) | ||||
Synonyms | Really interesting new gene 3 protein; RING3; O27.1.1; KIAA9001 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BRD2 | ||||
Biochemical Class | Bromodomain | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 15-Methyl-4-(methylsulfonylmethyl)-8-(naphthalene-1-carbonyl)-8,12,17-triazatetracyclo[8.6.1.02,7.014,17]heptadeca-1(16),2(7),3,5,10,14-hexaen-13-one | Ligand Info | |||
Canonical SMILES | CC1=C2C(=O)NC=C3N2C(=C1)C4=C(C=CC(=C4)CS(=O)(=O)C)N(C3)C(=O)C5=CC=CC6=CC=CC=C65 | ||||
InChI | 1S/C28H23N3O4S/c1-17-12-25-23-13-18(16-36(2,34)35)10-11-24(23)30(15-20-14-29-27(32)26(17)31(20)25)28(33)22-9-5-7-19-6-3-4-8-21(19)22/h3-14H,15-16H2,1-2H3,(H,29,32) | ||||
InChIKey | SVWVGWHDUPYUFQ-UHFFFAOYSA-N | ||||
PubChem Compound ID | 162371059 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7DPN Crystal structure of BRD2(BD1)with ligand ZB-BD-224 bound | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [1] |
PDB Sequence |
RVTNQLQYLH
83 KVVMKALWKH93 QFAWPFRQPV103 DAVKLGLPDY113 HKIIKQPMDM123 GTIKRRLENN 133 YYWAASECMQ143 DFNTMFTNCY153 IYNKPTDDIV163 LMAQTLEKIF173 LQKVASMPQE 183 EQEL
|
|||||
|
||||||
PDB ID: 7DPO Crystal Structure of BRD2(BD2)with Ligand ZB-BD-224 bound | ||||||
Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | No | [2] |
PDB Sequence |
GSHMEQLKHC
353 NGILKELLSK363 KHAAYAWPFY373 KPVDASALGL383 HDYHDIIKHP393 MDLSTVKRKM 403 ENRDYRDAQE413 FAADVRLMFS423 NCYKYNPPDH433 DVAMARKLQD444 VFEFRYAKMP 454 D
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structure Base Design of A new chemotype of Four-Cycle Compounds as Bromodomain and Extra-Terminal (BET) Inhibitors with The Second Bromodomain Bias and Highly Anti-inflammatory Potency | ||||
REF 2 | Structure Base Design of A new chemotype of Four-Cycle Compounds as Bromodomain and Extra-Terminal (BET) Inhibitors with The Second Bromodomain Bias and Highly Anti-inflammatory Potency |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.